0000105770-23-000026.txt : 20230428 0000105770-23-000026.hdr.sgml : 20230428 20230428160614 ACCESSION NUMBER: 0000105770-23-000026 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230425 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230428 DATE AS OF CHANGE: 20230428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 23865932 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 wst-20230425.htm 8-K wst-20230425
0000105770false00001057702023-04-252023-04-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) – April 25, 2023
wstlogoq319.jpg
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania
1-8036
23-1210010
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
530 Herman O. West Drive, Exton, PA
19341-0645
(Address of principal executive offices)
(Zip Code)
 Registrant’s telephone number, including area code: 610-594-2900
Not Applicable
(Former name or address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.25 per shareWSTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1

Item 5.07 Submission of Matters to a Vote of Security Holders.

Our 2023 Annual Meeting of Shareholders was held virtually on April 25, 2023.

Our shareholders voted on five proposals at the Annual Meeting. The proposals are described in detail in our proxy statement dated March 15, 2023. As of March 3, 2023, the record date, there were 74,269,938 shares of our common stock outstanding. Shareholders representing 67,444,781 or 90.81%, of the common shares outstanding were present virtually or were represented by proxy at the Annual Meeting. The final results for the votes on each proposal are set forth below.

Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2024 Annual Meeting of Shareholders by the following vote:

NameForAgainstAbstainBroker Non-Votes
Mark A. Buthman64,658,097113,624602,7472,070,313
William F. Feehery55,002,4372,878,9447,493,0872,070,313
Robert F. Friel62,935,621969,2171,469,6302,070,313
Eric M. Green60,170,150281,3254,922,9932,070,313
Thomas W. Hofmann61,851,061462,4303,060,9772,070,313
Molly E. Joseph64,827,64363,822483,0032,070,313
Deborah L. V. Keller62,842,349936,2771,595,8422,070,313
Myla P. Lai-Goldman65,133,00769,433172,0282,070,313
Stephen H. Lockhart65,094,28051,507228,6812,070,313
Douglas A. Michels62,752,334441,3772,180,7572,070,313
Paolo Pucci62,937,309968,5201,468,6392,070,313

Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:

ForAgainstAbstainBroker Non-Votes
62,330,6062,954,86588,9972,070,313

Proposal 3: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2023 fiscal year by the following vote:

ForAgainstAbstain
62,221,8625,198,46824,451

Proposal 4: Our shareholders approved, on an advisory basis, the frequency of votes on executive officer compensation by the following vote:

1 Year2 Years3 YearsAbstain
64,486,69615,575838,35933,838

Proposal 5: Our shareholders rejected the shareholder proposal regarding fair elections by the following vote:

ForAgainstAbstainBroker Non-Votes
7,047,21258,183,766143,4902,070,313





2

Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit No.
Description
 104
The cover page from the Company’s Current Report on Form 8-K, dated April 25, 2023, formatted in Inline XBRL.



3




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


WEST PHARMACEUTICAL SERVICES, INC.
/s/ Bernard J. Birkett
Bernard J. Birkett
Senior Vice President, Chief Financial and Operations Officer
April 28, 2023



4





EXHIBIT INDEX

Exhibit No.
Description
104
The cover page from the Company’s Current Report on Form 8-K, dated April 25, 2023, formatted in Inline XBRL.
5
 EX-101.SCH 2 wst-20230425.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 wst-20230425_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 4 wst-20230425_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 5 wst-20230425_g1.jpg GRAPHIC begin 644 wst-20230425_g1.jpg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end XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page
Apr. 25, 2023
Cover [Abstract]  
Entity Central Index Key 0000105770
Document Type 8-K
Document Period End Date Apr. 25, 2023
Entity Registrant Name WEST PHARMACEUTICAL SERVICES, INC.
Entity Incorporation, State or Country Code PA
Entity File Number 1-8036
Entity Tax Identification Number 23-1210010
Entity Address, Address Line One 530 Herman O. West Drive
Entity Address, City or Town Exton
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19341-0645
City Area Code 610
Local Phone Number 594-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.25 per share
Trading Symbol WST
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
XML 7 wst-20230425_htm.xml IDEA: XBRL DOCUMENT 0000105770 2023-04-25 2023-04-25 0000105770 false 8-K 2023-04-25 WEST PHARMACEUTICAL SERVICES, INC. PA 1-8036 23-1210010 530 Herman O. West Drive Exton PA 19341-0645 610 594-2900 false false false false Common Stock, par value $0.25 per share WST NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.westpharma.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports wst-20230425.htm wst-20230425.xsd wst-20230425_lab.xml wst-20230425_pre.xml wst-20230425_g1.jpg http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "wst-20230425.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "wst-20230425.htm" ] }, "labelLink": { "local": [ "wst-20230425_lab.xml" ] }, "presentationLink": { "local": [ "wst-20230425_pre.xml" ] }, "schema": { "local": [ "wst-20230425.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "wst", "nsuri": "http://www.westpharma.com/20230425", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst-20230425.htm", "contextRef": "i3d6305851a6d4d2db6323802fff9b540_D20230425-20230425", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.westpharma.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst-20230425.htm", "contextRef": "i3d6305851a6d4d2db6323802fff9b540_D20230425-20230425", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0000105770-23-000026-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-23-000026-xbrl.zip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

P RZL>"JZOW(^A7OI8J/IUIGB^Z/3<3"H[ QVQFC9P@!U=[8 MZM-2Y=TK%T1WX&UH4!F^+DY"X2DQ>#@?XEK34(,!OO[(^6F=WT;Z/6FC,\=; MS2(RA;JX/SUX9ZT)TYZ'5L+6]LN0(W!9PPLD:IN?IVPEP2GJY5&U.)5CZV;/ M@L\>G3R4\V+LWW46Z/?0 J_CR/8('6X8C3:-(F=N!S8@8=8W0?5%5P(LIK *(>PS@9\I+8/KGBF/]NVHK7/_4U MC^C%\F^%0*5L]FH,MWTI,K:6)J5*[@EA92$6CX'L[ 8Q@_.$/GGA#Y+"K=>!;/O]-@L/>_@^$/X4^0]%NHB-@U;*S,\4S=Y10YX)T3\U M9*[P"D+6JTAZ)^9]S^)M1"=8F5-OGX]05?+V7EYWMSA97Q,H3;)\K1#Q'I_Z M!_\^'X-8315S$O*[)+\>=]:_<4 LGF*?F8)P.B6"FGX\%D]#). "VK?B/\*#/E/5J4=8H-1]8-ZN MSII(')S^[,D0:OBIS.NB.#3O]M7@'4"](I!6V\,XM_%QNXJ;?J.BT:F=/U_B M^&$[LW]E1[I/[!WO6H1W5R47YSY@3^Z6.Y&T35L]@+"0BXOF.8S40K7HTE0R M\]MKTY%"/W^05OI/JO3SU;N*RN].29UE7_J"%2>6";7=.],E%>E<5*^WL^5- M2YH Q>,TCN_W]IQ%E]SH&1C"YK1+VZ\FT63.D._I@1:S>G!(0R-9=(AKT<]JC["<',FGL;:8&?' M8*]PDU QI&H(Y5%4OYQEY1_5CP5290J>"RV[AXX'KIDB[US5_$111.USKE2']ZQRXI7"Z@>NP;)Z;-LB29IQ?Q[31$[D4ZM@&S92TAP]./,\$ MCIN(57Y909X:5/,MXZLHC"D-YOE4?]_?3/0BG2#S*0<5+,-V67E.'51)7U,H M0$[!*_(*?9TLR>(O\L-1%L,G__:OK<1)\12[O]'4BOFR]#GJ0:+<[TG:\]=: MDGJ&K?P_&Q0V&AVKUSV^8DD"XR$%;/:B$>\^K>NM5#72JG^ M?@D4$DM!C]F MET+QI&?Y.5RZ]8"T_NN=@-_N.B-<>8AVAF7UNZ$&U3V4.VRB([WWMJSUN^XG MC0)]F$X#9#6Q210\0S7R%NPX74"]!*:UG);JQ$55:O DY#*V<3R>P7L% (Q:>)Y MIX49T#QG1%YXB\H/=H30A,0I#X=\1GP8O"&RX3%5$J4)+5WR0@Y)BF,S#9;; M^/;&7T%-.\]%SI!YD'1'5J]/34I&S>:A27=QKQB*H-&792; ?UZ=$^&:LW=; M\=90@U.^<_B[3OF87]:%O]C>=E_&&/'8-\NR5.++]\LSZL)0FI;?VE^/!8Y> M]2@%?VXR$S!Z8?P!X_???IH6_6TU:M+\UF 5!-)+JF<(==S;CFE[?6.T+3UUZS MU'\EN?(H.,/OZM\L!3K5J?OT.87= M7J)X%H$\TYEZU6+MA\_!=+;Z&BQ@T=P-#UH(YP4/X$:^)W/!"+4&=K]R%YTQ=XKU(.D M2'U8A*%4?E?!HX/;;L^_'WZ^WRWKWM=/>_)#0IY^&#C4R$75@6XHKL(_!!Q^ M5LEKNE3F&#"D;+\=_+QRIR].(41%/R&X_^;&#EQ5W&3?E5X3]' ,Y8.)'[M> M'PAN.UL[!1C?I9%97?R%0('EME8*I/$9NJIZ+:QV_1+9C'+JJ]2 -/AR7B+P M9857K;4&*+O;J0ZS9"3VNA)?Y8OGYT*Z&4_[2WXU4Y!7>Q(BMV!SKH!IDXH_9B(2VW[&].@6Z@;9)7[PGBJ:8-EA9] MAO7P YV90"TAY.O"R=/II'K+%+OD#,VO6[/5C=^HTN'Y7?3 $JV2EGO^V@$P MZ]L,!CJFR30BY%^0"M1LA*[KL5';@GN="6-![FN&),DW@J?C2XB-=>W0X_8/ MV[PWOG3FOP'$3@9K-/?([V'F4XB8-S@6GY=I"/S6;6*<2U"]3#RQZ.^=<0YU MEE%L&%XD(!"B>*>)XV1%>0XQ^.OXA\4=S%S.S.ZNJ'>&O_N/TQXMC-,&22O> MVQ">>_/VPHZ.V*#P=70^^%FI,U$VWC8-^VF1(U$_J7GH3*OKQPL'A.0H9-ZN M-I7;G#BV%":P5D UO,L8A50E12)E'+G8.\+>/TNWSOW@/J'K':H M$"*0['L@Y$.#/LX\_,Z2-":,V.,7H"J58^A5F%'U20S^/8N2,0%WS!N&0(V! M;X,]/L'JZANB7NCZ@QB4G2CH(;M0CLGZVP:?SO<^J,FBJ2!7FQVB]IGOH7^ZIWRLK7HH"1[Y<[>1R!U"66;5_AG5L+ (Y_$Z=OR7".?@^*@$; M;-?H MLT@2[T07PA7+RY(O*5#2S2D6]6-1ST:4TTB# 8H $P QUY)@C5&MMQ,W1G)3 M^A+OM.'AQ6=NF=\([%1F*:F7E:B6^V78V2]ASQ+P,'X0=8-4\*+*X&^1A>AN MJU5HB?/K*:GNHJW.Y*CP0HD*IP!# 'IV /26^$#F\+*&U#DW;4_VVC7YF>P^ MCGY#<@@6^'4,O9F]]G-Z"?W/&DMB+=VZ#FI!=Y;(!)[04#1;/A:!%4#^C62X M&?/WL"!.9,<#"NXB+MK[U8H.T<1 ;0QR$"5F:##KQ^.D/8,E9'645UT3*D_I MO3KS)E9BG,+MO?:--&IER9]'(EF:V9_0[QF;K;_O4J\+^X<:U&-PR M9.$[_WV]"A(I$6#=SV<_GWK'396J#W6>#3_D-*^:%^LL&,^-;?^MDYV;V\5$XA&19W\;E\<46?=F%^9-6NK8#4*> M=TA?RG3G$8C*MW&Y,C=IO7&P@6R"TF0L[K6SY@M+P_^556?UJ&3O9=B+' AH MQ>((G?2,7!9XMT,B,Y^EJ.SMZ0?E#814KES]_K;)ZVZ'M#6;_(N"$SZ8Q8ZZ M.6E7[!74['LTR8DN13D&\@20]CJ1?&/:TYJC!T[KFBR SU2_@"#PM*G<$I$^ MU^W?95">>&%':X.[X'7;V0F%"V>+2O,V?6OJ]?10"6==R<9=%S[>/9U#ML-: M1Z-99,T5.ON> B59"PB&>-\FC<6H[0YP@4,+"Y.C8S?B>=8U']UT5QI2$WOT M2SAZLH1[=O'$6$?;<4P^=K: Q?!NA7LSN"W(P=='% >GVHS%2.U"3H_"+'Y2 MK[QYX*[Y[UK+Y0SGL_%*K9SLBN^0GA(M)QX$8VKP2VZY+[Y6BH<2V$%?CJ8P82W>3[!*%G9^_"]-C)A1)HUZ M=KYG3T]F]2 )M">-70.-2(MM,\*#KCH'T*@J:KC:+ZUA$][[XL:@,QHQUAJ" MSKA\WG/6E;ZPG[GE%+Y&Q?)6]%"]/DRH!ZG9KNQ!V:&SL_!8EM>5J-G\'/D* M\Z3L[ZA<*K8N^ M4>?M?=3=.2V!!^#7/:8G2K=$-D.XQ6>#URQ(!:TH:$9NB$OKA5K@:.HG^Y0" MZN-_8ULX_9A32LV:=9._0O\9*6_ Q@48W#94"X09B">A\?Q9Y%-[U,-[=[X/ M/>MUXZ@T=Y,J2N;M"";V)*0;!21N68(T%05+"[/L>>6#L##TS>;0&0C; MF_=>'3]N5]DVPI;.\PLTFIPW_7=.D0F4+M\J&O#E4SZAO(-97 ^&(FNBM_&L MM+[!JJC;(9MXKO5\@BCH-PL1!0M:9E0\QG8&ORS;N)@7G"^[1NF??RG\("^5 M"[P;KMQ1!0<5<.L0#!O%[V4.M.4LMO%ONYSB9SK>QF4A>/+![OZU*W%$XR,E#L%Z-+>5D%S?^A0>(T$;+P#[JW MA.9RBE/S5ZIA13ON:)I@&^7SL)J=!LF[/3F-8S-MH?]8."R[17MX"4>ZA)I, M<;G1AI].+7(78&24.;2'R@C\1GKMIU^C?T+XL61!):NH$U0WKXN(AZLC"=5<9S&83! M'"M*X3 3:$YG J?"M?Z[,+\>6K60ZR]&;)OAJ[PUK@Y]\]F?JTSP#G&W+(Z% M(Y%N2,-5067G%>B1-7Z!WH"BZ0LF.='NN0*HSB:?0=9YOT&KQ-X'>)"Q71[' MFWU,?G<:?QJ#LT2,,G;]N@2L'&%#3OPRU7U3(=997#[\7ZC+1T)#YK!>VICM M:B6$JC(@@(&$43*[(CE]UG?5.-_'O\AEXC; M$851XEGFA"//,/K@7&H-,%8VO-&O3=HM+'.MK2'MO488A*2+2_WL_BOUSU3: MZWC*//;D18E[7%G765E32,<@9/*G!@I#:F]55:,U6@(*0=?C0\^DWY8,OF@/ M[O!_-AG=Q5)T ^ON7Y>#PQ(6&@G>]7KK\LF"I5730BU20M;DSY/)T:YW=H/O M'0YAC\V!0.,HX)JIMJ5^S9?LH>6_*)N*D(9$J_%[I%T9AT>IT[O[WT%Q%O?] M".Z2<42[[-G]!C8"AHL)/+KZH(F%K#IW2IYV/^%-,4R(D*.U/;Y?>[5+FJ\/ M^P>Z%D"5#M&ER($R^2&0EF<5YFZ/#*E3/:2QL.J)&_(_LZ,=I!XMM[X0O7B# M\P&R&?<=_A(URP)9SD^DI%=K0]X_7EXO6;W56A1:=I>S)?.6YD7I5]?>QC5O MP'Y\XP38FC']8&YL@$0^S+V?6KCN[KT_N3D_3A=^#;I$.< FJZD3OC,U6S#8 MA]Q\D9MP^? 6@Q8W"DVHT".PGS3'C:M-KJ\L).>'*R;I=63LKF-TL^GES^" MSJ_@& QU<&PW#.6.BW(8H"EC#Z%F7[*:7L(0>N(Y'NT7GZ'[]4X[T%6I9_1EXU6UZ&@.Q.(-6W]KB#965RF+W#BQ5!A[Z%O210TXM/W? MDVUGQ9&3L&2=K-&]VNOI-CA\&5>B;>Q!W[? >@=/[]"-T/3U$4(2: )U@\5F M%F:<\%;G7E&K,/"Y#?7PUT1^Q:;6RS@.JGR!5SLEO0U8X+-P+%I?^_C\1*;,6 M(8S/[:Q<&EH,]-ST:;JV2B@3#FU?[IU\HJ3L$\[PV'H55*S!!-3MF,#>+JHS M([#,H8M==])GZI&B[+T>BNPN_1Z$%686U\@,GH71CCFBR"+ER#X4W_VW^@@C MDN:YDY%JD5Y'3BQ"5QBINVBRZ$F__R[?CT U&U\/NTV]$XK'A^=*WE^--E"CI3%X+G *@,D&=8" MBVTZ >:3<*;U8TV0D*A0;2/K7MBKW@!\;[3"O/&M^!Z6R(E36]=$#FYE MQ>^MG= M[>FDR3BKVKF::^4^KD_"12MLSSV68"7-(EBSD0;+@M8?,J8ZX"+54_?] MPK]U"3KYZ/Q[VSG4IWO*J-DO^84G=^1K0(DJT&8L_K=!+O=2@:=C>&)JP63" M]\F)YN\F1U9?F[*9SRJ;NG$#S;/W[KDV\;RIPXEG7OKSDO)T9MD+5TP7:,3/ M<+>ZO[/-VU\)7FH4_$V["<+S$7?!0$R(O5/"UT&:>4'_UQFS.MY!R]=2'(L? M9?6W8QD/L;Y)XW)=*!(,%ZLK"8FKHF8\E?"5515NCSDJ)CGLH,#=\ZMD2J/I MM$'$;\TZQ8.8H.[5T4H$#'\7VG$@TYGU;?S.RL\@PEI=54.MP^S'H#:Y0WD> MPY)X?,X93,JPK^#"JUKXMVT#O?0HI8<[A+Q]#QGT\A)*7D,O6?,(U#+D=RO4 MDO&6]M]UUT[T#,9)K\.$5;QQM-L9U_;E)[WWRF#RJ3'-=.6T),813JH&SU\- MDLQJD?S^]=+I4%0:C5%]X X5WEIH7 F$#4*'::/(XPO2,_-7IQ89YML=YWM] M7V*=^ZXX'6QM!6?%3GF)W-1_\N'?[ M+?^SKPM,X"$6Q1!A0=@IK *"^ M;?2XOI5J825EMUIEO\($NO?]&$?_2XMJ$H8F'->L=5R-"> 56'3@C:OIF/9> M=*\]L"$VVM,3.VW-?U1E35=CJ7CW6H%;69A;9L8Q=G1KZEL=/6G[^9 &]\>V MGO;M5IFWIM'?[OL_]1_.O?PJU/6GW+X;O8ZE5 0$D=VH:L5X0PC!6SE+][K+ MQJ+ESTPM:2!)=V(CA.O=3#"\+C:76I992:5 S_8U:&8[;A5%E;QW:LP,"^_:UJV3)692 M"QA\OT%7M"!T-G?06^7F+$DQ:C/(]0G_1/X9SV-0VTRW74MZ*!R4QZW]2[P* M*L[R'M1\E-K/W,&]@E9"7Q@#<:])YB\16GA8S:D._\F':)GZW[$6ML]NI@'O M+AI__;&-%51R.V=[KLK34LUKS,=S3VHN1V:DA>A)*+:-?W]W#7.0O8,*0J8J MF$.X/^V**B!O)(UTJQ^5NJIW(I8FQ8+/>M!LE<)!QZB7/!UXC>/<;) BADS= M_5-6#>6X%&ALQ1;T>$AL?_+"F\>S,BGFN]!&(=[,?3<&]R)58!E="UG[7.AY MJ[KC:R/> E6[X]UK=2GPZ;LK"0O-;QR"0P?%KM>_4/V^>Q-NWCJ1;7C:V!CG M^&3($9ORMY(.^TA _/RJSJE^/__JJGA!/V(0_#R+!L\L%,\VYB'$Z%F;$Z'3 MNA%R\>EK./G47-92!"&L/G'H, & E;[C@OJAQA(Y.HME MF=*%@8 M"^QTW>_S#8:.+4.\!64(C3QOJ$,HMYI^,.;&K MXWA+T&_#X^6(NL7LS;&Q'_:5\?AMOZ#,]@>=,)]C= 2N*H^R:4,\LUH MLP5.>O*L')\&>43/81SOBVF1?%9P.N<9<=[%)[]KQ3AUTI0E[6$K-R?[Y.@Y M5<6>\0\Z3H7,=7^Y<8Y'D>(ETU3WF$(L1603X!'P\NER)A 3W(6)V=#5X:*= M]%;C\KT6PP3&*"6H:$B%7PLN"2K\%,5B; 18.Q,0 G/;U>?&68#>RB7BU<>F MMH'SWI>[PIE1_H*M/S1(\]K+@""O&YE6S_:']E?"W@X$CFM;BGZ:6OKAM']G MLP3KBTMD2;/;29,\%TEY.6R@ 7%3>,;B[/+WE:9C5L7A8A-93Q.WZK7,_8[+ M/7TEIN=2T@R9@HQG44Z3,&O>I)^J6F9_$?HYI[30K3N*YRG.MYZ\F3)VV^_$H-SSC.$/YLCN?<"T?\7]TLJ=0XOFC_ MGM];?^K/_!7.EW+UPY=_&_NGVV:6;YOG_36A63[8VU7TT_*KH&,!>&^ZG2H5 M89C-*NUFZ.W*H';FK\8-S8P%+#%@ M6)QQ3#-CR=1M$I?E90J]-_D]>Y8NJB! M2V-1@_33+\^7,MF!S,@1$7DVK8O! 6B1"$/2HNJ$^ (5P9=!E\R='>0;YW\( MW?]#I?P(/\N_6U'O%G_8?6"?XD?[EIIRG5EO=US*^7.B9/7,F*U'-PN4K?CL M6?J$=WV#Q7J.+< ,YUUWV?S;:YUX-IN$D"]W:Y=E(DS\>5GW6O;%#A7'QGA_S1#=_6/[<_ M<)]_W9[L1[G&CA^^]1?6KGU=[IF9FI@M*1QS[GG6,9%ZL2++%XSG&,[6O3TD M>4Y?=GID:$^LKKQ)],6;[^39 M/P#VL;:D[EN?G:Q^<+YL]^R;+8+\F[3==TPPNJ0MZOI\6@Z#4?'1NKOU!S7J M'TR7XO\CO/EA])W[)U/7_O'[J,/YGX&3;]O$1-WKBOL.9D5/W=;;EK,MVIDSB%=53Z'KT,%= X=.>FZI)1Z;E M)#J&_,Q8M%=GUYK';GN2;OEI_:O[=.?3QRL/M;;$3,HUS]>UDH]VY>@\9GQI M:?!$5]%G^OX&9?=H%A+8K4 M!XLV@VZF'12;:8LF10>[6!C\4B+4E@)9:9)_OZ1L)U8LV:1DJYJ7Q+&O+\\] MX;F\EZ3]^M?[^0S\4,4BS;,W)^BE=P)4)G*99E=O3KY>OH?QR:^G+UZ\_AN$ M?_[KRSGX+1>W([2(I\#K[EQ??T!X/PM'K367[S M4*17UR7P/1\_?[5XE7@A$Z'@4,2A!TF )&2,<1CYF I"_5 1],O5*Z6XCP(9 M0:(HA810!KE, N@E(I+*CT.%H\KI+,V^OS(_.%LHH(/+%M6?;TZNR_+FU61R M=W?W\IX7LY=Y<37Q/0]/UM8G*_/[+?L[7%DC2NFD>O71=)$V&6JW:/+G'^<7 MXEK-&4RS17*#5POP%UV;0/ 61#S%Z>;^0)Z0S]44EP/S^^N5#ZY!T8BPFF;HR_]G/JDAS>5&RHCQG7,TT^LI;^7"C MWIPLTOG-3*V?NRY4TNQV5A0UKP8E-2A1:%#^O6VP20_X!\);;F,] +@JW(^' MPKB+TX\'@WNI\X,Z/N"-87I#7DZH=YD<:NX^#M4;^O$1'VI:Y"6;#3 MGH;9 M@#PS3YSK1ZMAC*,=R;0:9Y6Z-Z"J^U)E4BVS9OAJC-T#G#A$5K8HM%"+_+803VO;?-:T8.FURJQN\233XRYNV.H-&J4I Y; M3]<8P1HD,"A?3Y[BZ4#B[.C4S$;%2BYJ2&:F#,B+YZ'G8F_H3[)::-15W LE M7E[E/R;ZK1-3;9D'T#RHU-3J<++U;WM;K%&R0NSA>&4Q$;FN<&Y*6*/;5(1V MX92YW7]\29L>] 3DA52%KED; FB<=\CGEVDY4],XPBK"7@Q9X$E($H] BE $ M0Q+R6"B?"W?AKIV/3;05*) G /G_X/\$:[CNJGUDSUZQ73@YLEI=Z>@DU^=Q M]Y+JH[/!9?H\C":);MFXR_.;]J,7X;-\/K_-TF57M)A2O8@*ID*H8J4@D<2' M,98"1@HA)1-&0H%L-=HXPMB$N@()ZBCM==I,XWZQ]B;GR(IUY,5)L#MC[Z3: M9H^#27=G0)OZW6WH+F*SG3'[?)UGZN/MG*MBZL7(2Y3TH:]T74S\T(>4*@\F ML90BD"I"S%J_SYV/3;H5/E !!$N$]K+=(FZ_8OO0<62Q.C#A)-2VD#MI=,O9 M8/)L"V-3F:TV[J*\+)C9Q[UXF/-\-F6A%R:!"+08*8,$<0$IC[4L/9Y$0/:Q>\DP,98.ZFO[FDPZ34&L*F[ M9@-WT;W+2ET7?\A$7MSD1;6P7I2L5&?Y;586#V>Y5%."XL3#.((X,8<>2DE( M)0LA]VDHL&"!]+"M%"W&&YM EY!!#?,OH$*M:08KY,! MU>O#>_[-7U@-H^L M]$,0Z90&'.CIE!QL_ ^6,AR"W4PD+F_KFE[>2JGGT:+R^ZGX7.0_4AW.-(D] M$0N"( ^9SBLT9)#YE$#.2> %B(E$,+>\TCS02!/*"NR& M: 7=-("[^V^:,_ M:\,DC@Z$=4@7N]GHD2=:' ^<(':'MYT9]MB[IX3/A3)]O-)>S,V,#XO%K2HN MS;%6\2E)=$OIAX$*8UWT>YCI7CS!''+)"8P2@LR1FY*>=5K8-]C84H/&"\4& M8+!$#):00879/COLI7I_AC@D@4?.$KVXMLT3C"V%+$ MXY6V)4J@80*#TSXM-!.Y/Q?TIN?("<"9&2?1[XR^D]*;/0XF[YT!;6IZMZ&[ MD,_R'ZIXRQ=EP41I,>]J]B.:;Q4N\-\ULO\=9IXU1MMI?M4]#3:O&@/8G$_- M!EV;RW=S55REV=7O17Y77NO%YX9E#].(^HDD3%>-'HH@09Z"NJMD$'$<^XS& MH<\CM]ZR<9RQ+0ZK3FF-%2S!@A5:U[ZRF5K;MK(W8<-TE:Y<=6@I=S+1HZ-L M]CMP0[DSN.U^)AQT;R MK]1"'J1W[-4U_D7ZQ:,WBD=J$3/W1!6J1L-@T4 M]SRC<49]!(D?<4@3Y,,$21XS@C!)K(^JMMV/3>I/",$:HL--R6WV]@N['R=' M%K0+'6XW)5NC[G97[WG@^CE?E&SVG_1F>8U#ZL6/D@#24.ERF,42 M\E!@R#T1$.)C$2'>Z;BU-LS8A/C\[' )%FBTG6YL-#)KVQ'WY6N8AMB9JNZ' MK(U,]#]BK;O].0>LC:&U'J\V6W<_([G4;YV2D(>$*=W_HD"OM3%%D$8BA(%, ME&Z-DPCY@>O1B'$\-HD_[OL;<.['(!57]JBQ,_A.)QV;D?8ZX*@< M#7ZNL0F_Z3BC]KJ[U-YJ']+X>3]C5U/=;G+!,(=8$0E)X'F02:J+6^R1 F. M$I[8:JWF>6QB>P0'##I[M=7IVB^WSB0<66^6\3L)KC'63HJK>QI,7NF'15L]B&3ZO[?ZF$:(QI@)! ,>("U^'QSI1 E$,4RUFN?QT+IN56V MST88FPA7E=H*):A@ HW3M9I]3J1M(=N#GF%J6'MF.A2O+='WJ%N?>QRX9&T) M:+M:;3/L*N3WZ6S]03)D%DDB/)@D$8=$1#[D'$50*$4E]G3=2AV[TR?G(Y6O M >C\";PMXFPUVXV.8>1JPT0'H6Z'W$.C&\X&EN=V&-O*;+#IN7ED-J0^%9?Y M73:- Y]ZGL!0DB"$A$L,.?$P%%Q$4E>W@D;6!ZDM8XQ4HH][(=6.9EX @[7C MGM$&H8X;1MUH&GBWR(JA[EM%VQSTWR?:\/ES-HFV@VK=(6HP[2KP2W;_0>J5 M/$U6'Z5?K212)@$.$87"4\)\N:&Y>!^'>D7FOL2^KZMLZX_<[AQII&+7:$$= M;L?5N8U@6]D?@+9AQ._.6(<$L(>-'FF@S?/ R6!/@-LI8=\;>J[\JU_G::;0 M- RD4'&((4-409)$(62$!9 %&.NB(&*(.5ZD;!AEI GA<6U;/0 &+/B4=3TU MJA'K6 -TI6O@*L":J>Z50!,3_6N!FM>?4PTT!=9:#S0:=Q7^%W65FNO865E] MRV'$(T$1P5"KW7P;#F$PIGX /49T>4!%X(>.A4!]@)'*_0FDXU=%-I)HJ^_N MU PC;5M6.@BZ.?0>6G[F<& 9-X>SK> 6NS;Q;C*NY?[]],7ZF73Y5=JG+_X/ M4$L#!!0 ( ,: G%;4*<7+K08 .LP 4 =W-T+3(P,C,P-#(U7W!R M92YX;6S5FEMOVS@6Q]_S*;S>UV7,^R5H,LAFVD4PF6G09M#!OAB\'-I"9B6AW/?[]ZA_3\IY.#@S?_0.B/?W^XF/U<^^L-5.WL+(%M(+FYN;PUJ7RL$ZK!<68+1Y;SQ^:WSYK?\/ZUL08L^C_ M_;-I4[S4,'=+%G_\>O'1KV%C45$UK:U\9Z ICIK^Y$7M;=MK_G_]FOVP1?<+ M/39#W2E$*&+D\+8)\Y.#V>Q>CE27\ 'BK/O\_;1==D M<59G("[MJG.X[Z"]V\+QO"DVV_+/<^L$\7A^T[2H"RSF5'16__GUVL57![8) MFLQ,/^"+?.*AB\[8KL[ ;0M5@/MA/MHI:_^D4=F)7*?'*TOKH.S/+@,4R[[G M4]>TR?IV*:TV4EF-0'&"N*.9, (:!>ZLHT((+_73L7>.-]GS/B8-^,-5_661 M.UYT@G1?>F5Z59Z9NU=G-[_?5FW1WIUE09,MS[,(M[_ W9):,$X*A9C/=Q./ M6B#M\QWB*?.!,8F-X*/\?]'LTW%\&^?3Y&=U"I#RK/)HUR;_+.9/B7YHL=C: ME#M"?EV4X?'J;GK91_3:>I]:WD%'2 G"Q7W ?CC*?HAMGG2A;SD& MAL?Y^"JW71(!$(,.2$3@B!/)D*%&(TP54U2JJ.@XAK^U-BCT=+JAWUFYB43\ M$E)1A[=5^#FOPTON)<$&2Q2YS@-P I #9I#@3+B(F2&$["7T3\P.8H!-GX'= MM7QE&.[GKP^P*CHEJO8WNX&ED#Y*21PRW+,\?=&<4RG,$2;<&*$X!A@W#;QD M=1 *?+HHC%9R$B2O4"_\QZP]G]75>W.[.Z@!Y77-*J"@1M\;G9-MR MY"*SB H9M-* C8$]@/&73@SB1$R=D_WI/ ELWA4E_':]<9"6WE .T?"<\4#> M:5F/D1;*Y ,-W&+-(O=[8.2KQ4% R*D#L:."DXC^E;T]#UFK(A;WF]*'@2A' MI;8X(A(#15R'/!#"*%(F.BRY-%&SR$@JA4@SK!'QEN&@ (1G@ U?!][SA=,#X)#3QV.L9I."8RS_/5] MNJIOJB5F$ )6$8&E>0W4LIO[,D=GMK9?:'Q5?#@Z P?Q,H=M1S2DCT M>='[=)GJ+T7E89F]M9ADJL%WE=P\\R%+J4+8A7P"M.$A[H^+[ZP/JU3AOPD= M8Z2=$B*7==/:\K_%ML^;(7J6):"(Z)@WWM2IO/$* 0E*+56:BBCVD7"\9'L8 M'I.O9(Z6]97AZ&:]TP2V]SL0H8/W' D#>=[#FB(3I$-26D*B45Z', J';ZT- M V#"]XK#03[B,.4K"5P[_IU2T+51G]69S73WLD9HE=RHXYP("XG2>LGA6@F.' M< >O"SA&.VXE>-'L,! F7,0<+^8KT_"Q+@M?M$6U^C4G.*FPY5(2H[B/$3&3 M4V#N.47:&HD<(TX13+QDXU!X;G,8!Q,N4HZ4\94AN$S0$0PYL>T?T'4/^M/[ MF/U88NZQU9:BH+KW0*3.>:[)FV7!"7$&YS4.CZM._MCV,"@F7*CNV0H0AS5U$ HPG6G;E%;%/1)YY, R4"5C@S^ M2U:'O20UX:KC:"DG46U\NX&TRBC_)]4W[3HO;EM;W2TA!N>I ^2=\WE?Q#JB MA4)$$28Y,UK'